Names | |
---|---|
IUPAC name
(2,5-Dioxo-4-imidazolidinyl) urea
|
|
Other names
Glyoxyldiureide
5-Ureidohydantoin |
|
Identifiers | |
97-59-6 | |
3D model (Jmol) |
Interactive image Interactive image |
ChEBI | CHEBI:15676 |
ChEMBL | ChEMBL593429 |
ChemSpider | 199 |
ECHA InfoCard | 100.002.358 |
EC Number | 202-592-8 |
KEGG | D00121 |
PubChem | 204 |
RTECS number | YT1600000 |
UNII | 344S277G0Z |
|
|
|
|
Properties | |
C4H6N4O3 | |
Molar mass | 158.12 g·mol−1 |
Appearance | colourless crystalline powder |
Odor | odorless |
Density | 1.45 g/cm3 |
Melting point | 230 °C (446 °F; 503 K) (decomposes) |
Boiling point | 478 °C (892 °F; 751 K) |
0.57 g/100 mL (25 °C) 4.0 g/100 mL (75 °C) |
|
Solubility | soluble in alcohol, pyridine, NaOH insoluble in ethyl ether |
log P | -3.14 |
Acidity (pKa) | 8.48 |
Hazards | |
Safety data sheet | Allantoin MSDS |
NFPA 704 | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
> 5000 mg/kg (oral, rat) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Allantoin is a chemical compound with formula C4H6N4O3. It is also called 5-ureidohydantoin or glyoxyldiureide. It is a diureide of glyoxylic acid. Allantoin is a major metabolic intermediate in most organisms including animals, plants and bacteria and is produced as a degradation product of purine nucleobases by urate oxidase (or uricase) from uric acid.
Allantoin was first isolated in 1800 by the Italian physician Michele Francesco Buniva (1761–1834) and the French chemist Louis Nicolas Vauquelin, who mistakenly believed it to be present in the amniotic fluid. In 1821, the French chemist Jean Louis Lassaigne found it in the fluid of the allantois; he called it "l'acide allantoique". In 1837, the German chemists Friedrich Wöhler and Justus Liebig synthesized it from uric acid and renamed it "allantoïn".
Named after the allantois (an amniote embryonic excretory organ in which it concentrates during development in most mammals except humans and other higher apes), it is a product of oxidation of uric acid by purine catabolism. After birth, it is the predominant means by which nitrogenous waste is excreted in the urine of these animals. In humans and other higher apes, the metabolic pathway for conversion of uric acid to allantoin is not present, so the former is excreted. Recombinant rasburicase is sometimes used as a drug to catalyze this metabolic conversion in patients. In fish, allantoin is broken down further (into ammonia) before excretion.